Skip to search formSkip to main contentSkip to account menu

183C91

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oxazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine
Zolmitriptan is a serotonin (5‐HT) 1B/1D receptor agonist effective for the treatment of migraine. This analysis aimed to develop… 
2002
2002
Evaluation of the Effect of Xylometazoline on the Absorption of Zolmitriptan Nasal Spray
Zolmitriptan is a serotonin 5-HT1B/1D receptor agonist that is highly effective for the acute treatment ofmigraine.[1] Following… 
2002
2002
The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers: Food and zolmitriptan pharmacokinetics
1997
1997
The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide
AbstractObjective: This study investigated potential pharmacokinetic or pharmacodynamic interactions between the novel anti… 
1997
1997
No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
311C90 ("Zomig", zolmitriptan), is a novel and selective, centrally and peripherally acting 5 HT1B/1D receptor agonist in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)